Trump investment in Axon precedes ICE Taser bid, sparks ethics questions

President Trump bought between $1 million and $5 million of Axon stock on Feb. 10, weeks before ICE posted a notice seeking a $220 million, five-year Taser contract, prompting ethics experts to caution about potential conflicts of interest. Officials say there’s no evidence of wrongdoing and the procurement is still in process, while Axon’s growing federal footprint—already supplying DHS and offering cloud, evidence, and AI tools—could benefit from any expansion of ICE’s Tasers, potentially deepening ties between the company and federal law enforcement.